Square Pharmaceuticals PLC's next confirmed earnings release is scheduled for November 13, 2026.
| Earnings Date | 11/13/2026 |
As of the close on October 19, 2026, Square Pharmaceuticals PLC's stock has gained approximately 2.91% over the past 52 weeks. The 50-day moving average sits at 217.26, while the 200-day moving average is 215.51.
| 52-Week Price Change | 2.91% |
| 50-Day Moving Average | 217.26 |
| 200-Day Moving Average | 215.51 |
Square Pharmaceuticals PLC's most recent stock split took place on November 23, 2020 with a 20:21 split ratio.
| Last Split Date | 11/23/2020 |
| Split Ratio | 20:21 |
Already premium?